BLFS Q4 2022 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q4 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$44M+18.6% YoY

Gross Profit

$14M31.6% margin

Operating Income

-$10M-23.1% margin

Net Income

-$49M-111.1% margin

EPS (Diluted)

$-1.15

QoQ Revenue Growth

+8.6%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$3M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$450M

Total Liabilities

$86M

Stockholders' Equity

$364M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$37M	+18.6%
Gross Profit	$14M	$7M	+103.6%
Operating Income	-$10M	-$18M	+43.8%
Net Income	-$49M	-$15M	-223.2%

Revenue Segments

Service Revenue

$4M65%

Rental Revenue

$2M35%